A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

Name: A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
Published: 2022
License: Public Domain

NSABP Foundation Inc · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

chemotherapy colon-cancer

colon cancer, ctdna positive, adjuvant, signatera, gevokizumab, chemotherapy, stage ii, stage iii, microsatellite stable (mss), interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

Related documents